Literature DB >> 15951628

Multifactorial pathogenesis of falls as a basis for multifactorial interventions.

M Runge1, E Schacht.   

Abstract

Mesh：

Year:  2005        PMID： 15951628

Source DB:  PubMed          Journal:  J Musculoskelet Neuronal Interact        ISSN： 1108-7161            Impact factor:   2.041


× No keyword cloud information.
  16 in total

Review 1.  Osteoporotic fractures in Asia: risk factors and strategies for prevention.

Authors:  Jian-min Liu; Guang Ning; Jia-lun Chen
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

2.  Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).

Authors:  J D Ringe; P Farahmand; E Schacht; A Rozehnal
Journal:  Rheumatol Int       Date:  2007-03       Impact factor: 2.631

3.  Alfacalcidol in men with osteoporosis: a prospective, observational, 2-year trial on 214 patients.

Authors:  J D Ringe; P Farahmand; E Schacht
Journal:  Rheumatol Int       Date:  2012-04-08       Impact factor: 2.631

4.  Alfacalcidol improves muscle power, muscle function and balance in elderly patients with reduced bone mass.

Authors:  E Schacht; Johann D Ringe
Journal:  Rheumatol Int       Date:  2010-09-09       Impact factor: 2.631

5.  Assessment of musculoskeletal system in women with jumping mechanography.

Authors:  Yannis Dionyssiotis; Antonios Galanos; Georgios Michas; Georgios Trovas; Georgios P Lyritis
Journal:  Int J Womens Health       Date:  2010-08-09

Review 6.  Improving the outcome of established therapies for osteoporosis by adding the active D-hormone analog alfacalcidol.

Authors:  J D Ringe; E Schacht
Journal:  Rheumatol Int       Date:  2007-08-01       Impact factor: 2.631

7.  Potential of alfacalcidol for reducing increased risk of falls and fractures.

Authors:  J D Ringe; E Schacht
Journal:  Rheumatol Int       Date:  2009-01-22       Impact factor: 2.631

8.  Alfacalcidol treatment increases bone mass from anticatabolic and anabolic effects on cancellous and cortical bone in intact female rats.

Authors:  Xiao Qing Liu; Hai Yan Chen; Xiao Yan Tian; Rebecca B Setterberg; Mei Li; Webster S Jee
Journal:  J Bone Miner Metab       Date:  2008-08-30       Impact factor: 2.626

9.  Analyzing the problem of falls among older people.

Authors:  Yannis Dionyssiotis
Journal:  Int J Gen Med       Date:  2012-09-28

10.  Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain.

Authors:  Rafael Azagra; Genís Roca; Gloria Encabo; Daniel Prieto; Amada Aguyé; Marta Zwart; Sílvia Güell; Núria Puchol; Emili Gene; Enrique Casado; Pilar Sancho; Sílvia Solà; Pere Torán; Milagros Iglesias; Victòria Sabaté; Francesc López-Expósito; Sergio Ortiz; Yolanda Fernandez; Adolf Diez-Perez
Journal:  BMC Musculoskelet Disord       Date:  2011-01-28       Impact factor: 2.362
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.